Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations | MicrobiomeTrials
Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2023-12-01Est. Completion: 2027-12-31
Enrollment target: 80 participants
Locations
Chest clinic, Chandigarh, Chandigarh, India
Other microbiome trials you might be interested in